Head and Neck Cancers Coverage from Every Angle
Advertisement
Advertisement

Carryn M. Anderson, MD, on Managing Severe Oral Mucositis Without Compromising Tumor Control

Posted: Tuesday, March 10, 2020

Carryn M. Anderson, MD, of the University of Iowa Hospital, discusses her clinical findings on the investigational agent GC4419: how it is used and whether it offers significant relief to patients with head and neck cancers without interfering with their treatment.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.